Printed on 6/29/2026
For informational purposes only. This is not medical advice.
The STONE score uses five clinical variables (Sex, Timing of pain onset, Origin/race, Nausea/vomiting, Erythrocytes in urine) to predict the probability of ureterolithiasis in emergency department patients presenting with flank pain. It helps guide imaging decisions. After confirming a kidney stone, assess recurrence probability with [ROKS Nomogram](/tools/roks-nomogram). Monitor renal function with [eGFR Calculator](/tools/egfr-calculator) and [Creatinine Clearance](/tools/creatinine-clearance). In severe cases with sepsis, assess with [qSOFA Score](/tools/qsofa) and [SOFA Score](/tools/sofa-score).
Formula: STONE = Sex (M=2) + Timing (<6h=3, 6-24h=1) + Origin (non-Black=3) + Nausea (1-2) + Erythrocytes (3). Range 0–13.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
Record sex (male scores higher due to higher stone prevalence), time since pain onset (shorter duration = higher score), race (non-Black scores higher based on epidemiologic stone prevalence data), nausea or vomiting, and presence of hematuria on urine dipstick or microscopy.
Add all variable scores: Sex (male +2), Timing under 6 hours (+3), 6–24 hours (+1), Origin non-Black (+3), Nausea (+1), Vomiting (+2), Erythrocytes present (+3). Maximum score is 13.
Low score (0–5): ~10% probability — evaluate alternative diagnoses. Moderate (6–9): ~50% probability — CT typically required. High (10–13): ~90% probability — diagnosis highly likely, proceed with clinical management. For confirmed stones, assess recurrence with [ROKS Nomogram](/tools/roks-nomogram) and renal function with [eGFR Calculator](/tools/egfr-calculator).
Emergency physicians, EM residents
The primary use of the STONE score is deciding whether to obtain non-contrast CT abdomen/pelvis — the gold standard for nephrolithiasis but a source of radiation and cost. High scores support CT imaging; low scores redirect attention to alternative diagnoses.
Urgent care physicians, rural ED providers
In facilities without immediate CT access, a high STONE score provides clinical confidence to begin empiric management (analgesia, IV fluids, alpha-blockers) while awaiting imaging or arranging transfer. A low score avoids unnecessary CT in a resource-constrained environment.
Emergency physicians treating young patients
Renal colic commonly affects patients aged 20–40 who are sensitive to cumulative radiation exposure from repeat CT scans. For high-STONE-score patients with classic presentation and prior stone history, some clinicians use ultrasound-first or empiric management to avoid radiation.
Radiologists, clinical researchers
The STONE score provides a validated pre-test probability for ureterolithiasis that can be combined with imaging findings (CT, ultrasound) using Bayesian reasoning to improve diagnostic confidence, particularly for equivocal imaging results.
ED quality directors, hospital administrators
STONE score-based imaging protocols can reduce unnecessary CT utilization in the ED while maintaining diagnostic accuracy. Integration into clinical pathways supports standardized, evidence-based care for flank pain presentations.
A negative urine dipstick does not rule out ureterolithiasis. If the clinical presentation is otherwise classic (colicky flank pain radiating to groin, male patient, nausea), a high STONE score still supports evaluation for stones even without hematuria. The score accounts for this — maximum score is achievable without the erythrocyte component.
Once kidney stone is confirmed, tamsulosin 0.4 mg daily is commonly prescribed to facilitate spontaneous passage for stones 5–10 mm. Stones under 5 mm usually pass spontaneously; stones over 10 mm usually require procedural intervention (ESWL or ureteroscopy). Assess renal function with [eGFR Calculator](/tools/egfr-calculator) before prescribing.
An infected obstructed kidney (urosepsis from obstructing ureteral stone) is immediately life-threatening. Any patient with a STONE score suggestive of nephrolithiasis who also has fever (>38°C), chills, or leukocytosis needs urgent imaging and urology consultation for emergent decompression (ureteral stent or nephrostomy). Assess with [qSOFA Score](/tools/qsofa).
Low-probability patients (score 0–5) have about a 10% chance of kidney stone. The differential for acute flank pain is broad: musculoskeletal strain, pyelonephritis, ovarian cyst or torsion, appendicitis, AAA in older patients, and herpes zoster. A low STONE score should prompt systematic evaluation of alternatives rather than assuming stone disease.
The STONE score does not include prior stone history, which is one of the strongest predictors of recurrent nephrolithiasis (50% 5-year recurrence rate). Clinicians should add significant weight to any STONE score for patients with a documented prior stone history.
The STONE score was derived and validated by Moore et al. (2014) in a prospective cohort of 491 ED patients with flank pain, achieving an AUC of 0.83. AUA Stone Disease Guidelines (2016, updated 2019) recommend non-contrast CT as the gold standard for stone diagnosis, with clinical scoring tools supporting the decision to image.
Your STONE score estimates the probability that your flank pain is caused by a ureteral stone. A low score (0 to 5) corresponds to approximately a 10% probability of ureterolithiasis, meaning most patients in this range have an alternative diagnosis such as musculoskeletal pain, pyelonephritis, or ovarian pathology. A moderate score (6 to 9) indicates roughly a 50% probability, placing the diagnosis in an uncertain zone that typically warrants imaging confirmation. A high score (10 to 13) indicates approximately a 90% probability of a ureteral stone, providing strong clinical confidence in the diagnosis.
The score is most useful for guiding imaging decisions. In the high-probability group, the diagnosis is sufficiently likely that some clinicians may forgo CT scanning in select cases (particularly young patients where radiation exposure is a concern) and proceed with empiric management and ultrasound. In the low-probability group, the differential diagnosis is wide and further workup targeting alternative causes may be more productive than a CT specifically for stones.
The STONE score is designed for use in the emergency department when evaluating patients who present with acute flank pain suspicious for renal colic. It is most valuable when deciding whether to obtain a non-contrast CT abdomen and pelvis, the gold standard for stone diagnosis but a source of ionizing radiation and healthcare costs.
It is particularly helpful in situations where imaging resources are constrained, such as in urgent care centers or resource-limited settings. For patients with a high STONE score and classic clinical presentation, clinicians may choose an ultrasound-first approach or empiric trial of analgesics and hydration. For patients with low scores, the tool redirects clinical attention toward alternative diagnoses that may require different imaging or workup.
The STONE score was derived and validated in US emergency department populations and may not generalize equally to all settings or demographics. The inclusion of race as a scoring variable (non-Black patients receive additional points) reflects epidemiologic data on nephrolithiasis prevalence but may be viewed as a limitation of the score's construction.
The score predicts the probability of having a stone but does not assess stone size, location, likelihood of spontaneous passage, or the presence of complications such as hydronephrosis, infection, or renal impairment. These clinically important factors still require imaging and laboratory evaluation. A high STONE score does not eliminate the need for CT in patients with signs of complicated stone disease (fever, solitary kidney, persistent vomiting, or elevated creatinine).
The STONE score also does not account for prior stone history, which is one of the strongest clinical predictors of recurrent nephrolithiasis. Clinicians should integrate the score with the full clinical picture rather than using it in isolation.
For related assessments, see ROKS Nomogram, eGFR Calculator and Creatinine Clearance.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Predict kidney stone recurrence at 2 and 5 years using the validated ROKS nomogram. Enter stone history, composition, and BMI — get risk percentages and prevention guidance.
OpenClinicalCalculate eGFR with the CKD-EPI 2021 race-free formula to estimate kidney function and CKD stage from serum creatinine, age, and sex.
OpenClinicalCalculate creatinine clearance (CrCl) with Cockcroft-Gault to guide renal medication dose adjustments from age, weight, sex, and serum creatinine.
Open